Michelle Parker
Förmögenhet: 2 M $ per 2026-06-30
Förmögenhet: 2 M $ per 2026-06-30
Michelle Parker is currently the Chief Executive Officer & Director at Clarity Pharmaceuticals Ltd. She previously worked as the Head-International Clinical Research Operations at Novartis Australia Pty Ltd. Ms. Parker completed her undergraduate degree at The University of Sydney.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-20 | 1 013 000 ( 0,27 % ) | 2 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Verkställande Direktör | 2024-10-11 |
| Företag | Position | Slut |
|---|---|---|
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån